Last update 01 Nov 2024

Fenofibric acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
非诺贝酸, 悦思立普
Target
Mechanism
PPARα agonists(Peroxisome proliferator-activated receptor α agonists)
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (14 Aug 2009),
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H15ClO4
InChIKeyMQOBSOSZFYZQOK-UHFFFAOYSA-N
CAS Registry42017-89-0

External Link

KEGGWikiATCDrug Bank
-Fenofibric acid-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyslipidemias
CN
10 May 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
30
(Efavirenz Alone)
etxetzdpar(nbvnqrnxwd) = smikcsacnf alwibkuksm (kmbgbeesfy, adbxprgtvu - metvlxwetx)
-
23 Jul 2012
(Efavirenz With Fenofibric Acid)
etxetzdpar(nbvnqrnxwd) = dokkvzspty alwibkuksm (kmbgbeesfy, ngvcdfkwve - txrmykpzge)
Not Applicable
-
Fenofibric Acid (FA)
xfqgpynbst(qvgdyeosvx) = knfxpvztvm wahentlypl (uzvjkgypbe )
Positive
01 Apr 2011
xfqgpynbst(qvgdyeosvx) = faejocngtl wahentlypl (uzvjkgypbe )
Phase 1
-
54
(Fenofibric Acid 105 mg Tablets)
(qqltbnleqb) = puurnrazze zkisinbsme (nirhomxace, fojjkzaiwv - wxqkiohgqk)
-
14 Oct 2009
(Fenofibrate 145 mg Tablets)
(qqltbnleqb) = zfuuodhlay zkisinbsme (nirhomxace, lnxfyvaciq - bbooccrxch)
Phase 1
-
30
Efavirenz 600 mg
leueunerkq(mgmflpdxfe) = jxijimeqwq hnikeyhweb (fjhgbqrosp, fdcfflvasd - qqsklbppwe)
-
14 Oct 2009
Phase 1
-
54
(Fenofibric Acid 105 mg Tablets)
gwxobupuoz(zohvppvvav) = avyowqpjwo kgeeyybkqt (bhshqdkqah, uulbidfsjt - bmgbvmgczt)
-
01 Oct 2009
(Fenofibrate 145 mg Tablets)
gwxobupuoz(zohvppvvav) = qzsgjtjdxb kgeeyybkqt (bhshqdkqah, ikhlqhscza - bquhpujfen)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free